CClaimWatch
Plaintiff counsel in 3 cases

Matthew E. Van Tine

Miller Law LLC

Address of record
115 South LaSalle Street, Suite 2910, Chicago, IL 60603, 312-332-3400
Email
mvantine@millerlawllc.com
Phone
(312) 332-3400
Fax
Fax (312) 676-2676

Contact details as filed with the court in the cases below.

3
Cases tracked
1 active · 2 settled
$216.9M
Plaintiff-side recovery
Disclosed settlement funds
—
Defense-side exposure
Resolved in settlements
2
Cases with values
of 3 tracked

Case history

Publicly tracked matters where this attorney is listed as counsel.

Plaintiff counselActive litigation — no settlement yet

Boehringer Ingelheim Pharmaceuticals Antitrust Class Action

The plaintiff, a labor health and welfare fund, filed this proposed class action against Boehringer Ingelheim Pharmaceuticals, Inc., apparently alleging antitrust violations related to pharmaceutical products. The case has been consolidated into a multidistrict litigation (MDL) with other similar cases. These are allegations in a newly filed case, not proven facts and not yet a settlement.

Filed
March 6, 2024
Represents
Massachusetts Laborers' Health & Welfare Fund
Plaintiff counselSettled — claims closed

Tuna Direct Purchaser Antitrust Settlement

Defendants allegedly conspired to fix, raise, and maintain prices that direct purchasers paid for packaged tuna products between June 2011 and July 2015, causing class members to pay more than they otherwise would have. Defendants deny all liability and have agreed to settle to avoid litigation risks, while admitting no wrongdoing.

Settlement fund
$64.8M
Claim deadline
October 18, 2024
Represents
Debra L. Damske, Ken Dunlap, Barbara E. Olson, John Peychal, Virginia Rakipi, Adam Buehrens, Casey Christensen, Scott Dennis, Brian Depperschmidt, Amy E Waterman
Plaintiff counselSettled — claims closed

Tuna End Purchaser Settlement

From June 2011 to July 2015, defendants allegedly participated in an unlawful conspiracy to raise, fix, maintain, or stabilize the price of packaged tuna products at artificially high levels in violation of antitrust and unfair competition laws. The defendants deny many allegations and assert defenses but agreed to settle to avoid further litigation, trial risks, and costs.

Settlement fund
$152.2M
Claim deadline
December 31, 2024
Represents
Debra L. Damske, Ken Dunlap, Barbara E. Olson, John Peychal, Virginia Rakipi, Adam Buehrens, Casey Christensen, Scott Dennis, Brian Depperschmidt, Amy E Waterman

“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.